Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin
Completed · Phase 1 · NCT05306379
Conditions: Drug-drug Interaction
At a glance
- Research payments reported, 2025
- $824
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 24
About the trial
- Sponsor
- Aurinia Pharmaceuticals Inc.
- Tested
- Simvastatin (drug), Voclosporin (drug)
- Dates
- Started 2022-01-24; completion 2022-04-05
- Results posted
- Not yet
A single-center, open-label, Phase 1, drug-drug interaction study to investigate the effect of voclosporin on the pharmacokinetics of simvastatin and simvastatin acid in healthy volunteers.
From ClinicalTrials.gov, last updated 2022-04-20. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Aurinia Pharma U.S., Inc. reported $824 in research payments for this study in 2025 (1 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Fortrea Clinical Research Unit Inc. $824
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.